カテゴリ： Grand View Research, 北米, 医療/バイオ

多血小板血漿（PRP）のアメリカ市場2020-2027：種類別（純粋PRP、白血球リッチPRP）、用途別（スポーツ医学、整形外科）、最終用途別、地域別

◆英語タイトル：U.S. Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type (Pure PRP, Leukocyte Rich PRP), By Application (Sports Medicine, Orthopedics), By End Use, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード：GV20NV152
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年9月1日
◆ページ数：105
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：アメリカ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,020,300見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、多血小板血漿（PRP）のアメリカ市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、ビジネス環境分析、種類別市場規模、用途別市場規模、最終用途別市場規模、企業概要などの項目を掲載しています。
【レポートの概要】

U.S. Platelet Rich Plasma Market Growth & Trends

The U.S. platelet rich plasma market size is estimated to generate USD 364.6 million by 2027, expanding at a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Platelet-rich plasma (PRP) has gained significant popularity in the field of orthopedics, neurosurgery, ophthalmology, and cosmetic surgery as it integrates modern technology with the body’s capability to accelerate healing. A rise in the incidence of musculoskeletal disorders, orthopedic disorders, and sports injuries has encouraged clinicians to embrace minimally invasive platelet rich plasma therapy with less risk of therapy-associated adverse effects, which propels the market growth.

As per the International Osteoporosis Foundation, around 52.0 million people suffered from osteoporosis or low bone mass in 2010 and are expected to reach 61.0 million by 2020 in the U.S. Besides, platelet rich plasma injections have been highlighted in numerous medical journals as a promising technique to heal damaged tissues. The studies have reported improved function and lesser pain after receiving these therapies than traditional standard care, thus driving its adoption rate.

Platelet rich plasma-based therapies continue to evolve as a popular treatment in the dermatology field. It is increasingly being preferred for skin rejuvenation, hair restoration, dermal augmentation, acne scars, and striae distensae. Moreover, the combination of platelet rich plasma with laser therapies, dermal fillers, micro-needling, and autologous fat grafting generates synergistic effects that lead to optimized aesthetic outcomes. The confluence of these factors boosts the penetration of these therapies in dermatology applications.

The emergence of platelet rich plasma products for point-of-care settings is another factor fostering market progression. Several POC systems are available in the market place that is specifically engineered and validated to deliver fast POC treatments within a few minutes. HEALEON HD PRP from HEALEON MEDICAL, INC., is one such FDA-approved Class II medical device that is designed for autologous platelet rich plasma preparation at the patient’s POC settings.

U.S. Platelet Rich Plasma Market Report Highlights

• The leukocyte-rich platelet rich plasma segment is expected to witness a significant increase in the commercial pool and number of experimental studies expanding its applications across orthopedic, general surgery, and sports medicine

• Numerous advancements in leukocyte PRP market space by manufacturers, mainly in protocol automation to maximize the standardization of plasma preparations are driving the segment

• The cosmetic surgery and dermatology application segment is expected to foresee the highest growth rate during the overcast period

• This is due to a rapid increase in preference among the consumers as injections based on this therapy help to achieve fuller facial features without opting for commercial fillers

• Platelet rich plasma systems are estimated to witness the fastest growth rate throughout the forecast period in the sports medicine application

• The advent of novel separation systems by key manufacturers that are specific to platelet rich plasma applications as well as functions vertically and are applicable across autologous cellular therapies boost the growth of these systems

• Numerous medical visits, high burden of orthopedic disorders particularly in geriatric population, and widespread application of this therapy for musculoskeletal injuries result in the dominant share of hospitals in 2019

• More than 300,000 old aged people, over 65 years, are hospitalized for hip fractures every year in the U.S.

• This high hospitalization rate surges the incorporation of platelet rich plasma as an adjunctive use in hip surgeries in hospital settings

• Key manufacturers are implementing business strategies such as broadening of product portfolio, widening of distribution network, and collaborations and mergers to reinforce their significant share in the market.

【レポートの目次】

Table of Contents

Chapter 1 The U.S. Platelet Rich Plasma (PRP) Market: Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 GVR’sinternal database
1.4.3 Secondary sources
1.4.4 Primary research
1.4.5 Details of primary research
1.5 Information or Data Analysis
1.5.1 The U.S. platelet rich plasma (PRP) market: Segment revenue and growth analysis
1.5.2 Data analysis models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity flow analysis
1.7.1.1 Approach 1: Commodity flow approach
1.7.1.2 Approach 2: Country-wise market estimation using bottom up approach
1.8 The U.S. Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 The U.S. Platelet Rich Plasma (PRP) Market: Executive Summary
2.1 Market Outlook
2.2 Competition Milieu
2.3 Segment Outlook
2.4 Market Summary, 2019 (USD Million)
Chapter 3 The U.S. Platelet Rich Plasma (PRP) Market: Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Parent Market Lineage
3.3 Market Dynamics
3.3.1 Market drivers analysis
3.3.1.1 Rise in the incidence of orthopedic disorders and sports injuries
3.3.1.2 Increasing number of cosmetic surgery procedures
3.3.1.3 Extending medical applications of platelet rich plasma
3.3.2 Market restraint analysis
3.3.2.1 High costs associated with PRP products
3.4 Penetration & Growth Prospect Mapping, by Application, 2019
Chapter 4 The U.S. Platelet Rich Plasma (PRP) Market: Business Environment Analysis
4.1 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
4.2 Porter’s Five Forces Analysis
Chapter 5 The U.S. Platelet Rich Plasma (PRP) Market: Type Business Analysis
5.1 The U.S. Platelet Rich Plasma (PRP) Market: Type Movement Analysis
5.2 Pure PRP
5.2.1 The U.S. pure PRP market estimates and forecast, 2016 – 2027 (USD Million)
5.3 Leukocyte Rich PRP
5.3.1 The U.S. leukocyte rich PRP market estimates and forecast, 2016 – 2027 (USD Million)
5.4 Others
5.4.1 The U.S. PRP market estimates and forecast for others, 2016 – 2027 (USD Million)
Chapter 6 The U.S. Platelet Rich Plasma (PRP) Market: Application Business Analysis
6.1 Orthopedics
6.1.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2016 – 2027 (USD Million)
6.2 Sports Medicine
6.2.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2016 – 2027 (USD Million)
6.2.2 PRP injections
6.2.2.1 The U.S. platelet rich plasma (PRP) injections market estimates and forecast for sports medicine, 2016 – 2027 (USD Million)
6.2.3 PRP kits
6.2.3.1 The U.S. platelet rich plasma (PRP) kits market estimates and forecast for sports medicine, 2016 – 2027 (USD Million)
6.2.4 PRP systems
6.2.4.1 The U.S. platelet rich plasma (PRP) systems market estimates and forecast for sports medicine, 2016 – 2027 (USD Million)
6.3 Cosmetic Surgery and Dermatology
6.3.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for cosmetic surgery and dermatology, 2016 – 2027 (USD Million)
6.4 Ophthalmic Surgery
6.4.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2016 – 2027 (USD Million)
6.5 Neurosurgery
6.5.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2016 – 2027 (USD MILLION)
6.6 General Surgery
6.6.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for general surgery, 2016 – 2027 (USD Million)
6.7 Others
6.7.1 The U.S. platelet rich plasma (PRP) market estimates and forecast for others, 2016 – 2027 (USD Million)
Chapter 7 U.S. Platelet Rich Plasma (PRP) Market: End-Use Business Analysis
7.1 The U.S. Platelet Rich Plasma (PRP) Market: End-use Movement Analysis
7.2 Hospitals
7.2.1 The U.S. platelet rich plasma (PRP) market for hospitals, 2016 – 2027 (USD Million)
7.3 Clinics
7.3.1 The U.S. platelet rich plasma (PRP) market for clinics, 2016 – 2027 (USD Million)
7.4 Others
7.4.1 The U.S. platelet rich plasma (PRP) market for others, 2016 – 2027 (USD Million)
Chapter 8 The U.S. Platelet Rich Plasma (PRP) Market: Company Profile
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Johnson & Johnson
8.3.1.1 Company overview
8.3.1.2 DePuy Synthes
8.3.1.2.1 Company overview
8.3.1.3 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Arthrex, Inc.
8.3.2.1 Company overview
8.3.2.3 Financial performance
8.3.2.4 Product benchmarking
8.3.2.5 Strategic initiatives
8.3.3 EmCyte Corporation
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 DR. PRP America, LLC
8.3.4.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.5 Juventix
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Terumo Corporation
8.3.6.1 Company overview
8.3.6.2 Terumo BCT, Inc.
8.3.6.2.1 Company overview
8.3.6.3 Financial performance
8.3.6.4 Product benchmarking
8.3.6.5 Strategic initiatives
8.3.7 Zimmer Biomet
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Stryker
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 Growth factors involved in stages of wound healing
Table 3 Growth factors involved in wound healing with their origin
Table 4 Use of PRP in wound management
Table 5 Products and service providers: Knee OA injectable biologics
Table 6 Clinical trials performed until 2017 to supporting the data efficacy of biologics in sports medicine
Table 7 Manufacturers operating in the pure PRP market space

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 The U.S. PRP segment revenue modeling
Fig. 5 The U.S. sports medicine market segment revenue modeling
Fig. 6 Market research approaches
Fig. 7 Value chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 The U.S. platelet rich plasma (PRP) market snapshot, 2019 (USD Million)
Fig. 11 The U.S. platelet rich plasma (PRP) market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
Fig. 14 Incidence of arthritis in the U.S., by age
Fig. 15 Benefits of PRP treatment in cosmetic facial procedures
Fig. 16 Common cosmetic surgical procedures in 2019
Fig. 17 Cosmetic plastic demographic data in 2019
Fig. 18 Common minimal invasive procedures in 2019, U.S.
Fig. 19 Market restraint relevance analysis (Current & future impact)
Fig. 20 Penetration and growth prospect mapping, by application, 2019
Fig. 21 The U.S. platelet rich plasma (PRP) market SWOT analysis
Fig. 22 The U.S. platelet rich plasma (PRP) market Porter’s five forces analysis
Fig. 23 The U.S. platelet rich plasma (PRP) market: Type outlook and key takeaways
Fig. 24 The U.S. platelet rich plasma (PRP) market: Type movement analysis
Fig. 25 The U.S. pure PRP market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 26 The U.S. leukocyte rich PRP market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 27 The U.S. PRP market estimates and forecast for others, 2016 - 2027 (USD Million)
Fig. 28 The U.S. platelet rich plasma (PRP) market: Application outlook and key takeaways
Fig. 29 The U.S. platelet rich plasma (PRP) market: Application movement analysis
Fig. 30 The U.S. platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2016 - 2027
Fig. 31 The U.S. platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2016 - 2027
Fig. 32 The U.S. platelet rich plasma (PRP) injections market estimates and forecast for sports medicine, 2016 - 2027
Fig. 33 The U.S. platelet rich plasma (PRP) kits market estimates and forecast for sports medicine, 2016 - 2027
Fig. 34 The U.S. platelet rich plasma (PRP) systems market estimates and forecast for sports medicine, 2016 - 2027
Fig. 35 The U.S. platelet rich plasma (PRP) market estimates and forecast for cosmetic surgery and dermatology, 2016 - 2027
Fig. 36 The U.S. platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2016 - 2027
Fig. 37 The U.S. platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2016 - 2027
Fig. 38 The U.S. platelet rich plasma (PRP) market estimates and forecast for general surgery, 2016 - 2027
Fig. 39 The U.S. platelet rich plasma (PRP) market estimates and forecast for others, 2016 - 2027
Fig. 40 The U.S. platelet rich plasma (PRP) market: End-use outlook and key takeaways
Fig. 41 The U.S. platelet rich plasma (PRP) market: End-use movement analysis
Fig. 42 The U.S. platelet rich plasma (PRP) market for hospitals, 2016 - 2027 (USD Million)
Fig. 43 The U.S. platelet rich plasma (PRP) market for clinics, 2016 - 2027 (USD Million)
Fig. 44 The U.S. platelet rich plasma (PRP) market for others, 2016 - 2027 (USD Million)
Fig. 45 Strategy framework
Fig. 46 Market participation categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[多血小板血漿（PRP）のアメリカ市場2020-2027：種類別（純粋PRP、白血球リッチPRP）、用途別（スポーツ医学、整形外科）、最終用途別、地域別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 手術用ナビゲーションシステムの世界市場：用途別（ENT、整形外科、神経学、歯科）、テクノロジー別（電磁、光学）、最終用途別
    GV20MY075 / Grand View Research / 2020年3月17日 / 本調査レポートでは、手術用ナビゲーションシステムの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、用途別（耳鼻咽喉科、整形外科、神経外科、歯科、その他）分析、技術別（電磁、光学、その他）分析、最終用途別（病院、外来手術センター）分析、地域別分析、企業概要などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・競争分析 ・手術用ナビゲーションシステムの世界市場：用途別（耳鼻咽喉科、整形外科、神経外科、歯科、その他） ・手術用ナビゲーションシステムの世界市場：技術別（電磁、光学、その他） ・手術用ナビゲーションシステムの世界市場：最終用途別（病院、外来手術センター） ・手術用ナビゲーションシステムの世界市場：地域別 ・企業概要...The global surgical navigation systems market size is expected to reach USD 1.44 billion by 2027, exhibiting a 7.2% CAGR during the forecast period, according to a new report published by Grand View Research, Inc. Growing geriatric population along with rising prevalence of brain cancer, orthopedic degenerative and ENT among other target disorders and diseases is expected to propel the demand for surgical navigation systems (SNSs). Aging is considered as the greatest risk factor for the development of degenerative disorders of joints; such as osteoporosis. Rising geriatric population is expected to serve as a high-impact rendering driver for the market....
  2. 歯科用タービンの世界市場2020-2027：速度別（高速、低速）、最終用途別（病院、歯科医院）、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）
    GV20NV213 / Grand View Research / 2020年10月20日 / 本調査レポートでは、歯科用タービンの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、速度別（高速、低速）分析、最終用途別（歯科医院、病院）分析、地域別分析、競争分析などを整理しました。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・歯科用タービンの世界市場規模：速度別（高速、低速） ・歯科用タービンの世界市場規模：最終用途別（歯科医院、病院） ・歯科用タービンの世界市場規模：地域別 ・競争分析 ...Dental Turbine Market Growth & Trends The global dental turbine market size is expected to reach USD 172.2 million by 2027, expanding at a CAGR of 16.1%, according to a new report by Grand View Research, Inc. Rise in demand for restorative endodontic and cosmetic dentistry, along with growing oral health awareness are anticipated to facilitate market growth over the forecast period. In addition, technological advancements in dental handpieces are also expected to contribute to market growth. Technological advancements such as superior turbine suspension are anticipated to improve veneer preparations, margin refinements, and other restorative procedures, especially the ones requiring...
  3. 皮膚リサーフェシングの世界市場2020-2027：タイプ別（アブレイティブ、非アブレイティブ）、製品別、最終用途別、用途別、地域別
    GV20JN095 / Grand View Research / 2020年5月 / 本調査レポートでは、皮膚リサーフェシングの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、タイプ別（アブレイティブ、非アブレイティブ）分析、製品別分析、最終用途別分析、用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・皮膚リサーフェシングの世界市場規模：タイプ別（アブレイティブ、非アブレイティブ） ・皮膚リサーフェシングの世界市場規模：製品別 ・皮膚リサーフェシングの世界市場規模：最終用途別 ・皮膚リサーフェシングの世界市場規模：用途別 ・皮膚リサーフェシングの世界市場規模：地域別 ・競争分析...Skin Resurfacing Market Growth & Trends The global skin resurfacing market size is expected to reach a value of USD 378.4 million by 2027, expanding at a CAGR of 7.2%, according to a new report by Grand View Research, Inc. High incidence of medical conditions such as acne in adolescents and a rapidly aging population is anticipated to drive the market. High influence of social media and rise in usage of smartphones and photo editing applications is anticipated to fuel a desire for flawless and glowing face, thereby increasing the demand for the rejuvenation services. For instance, Facebook, YouTube, Instagram,...
  4. フェイスシールドの世界市場2020-2027：製品別（フルフェイスシールド、ハーフフェイスシールド）、最終用途別（医療、建設、化学薬品）、地域別
    GV20NV216 / Grand View Research / 2020年10月20日 / 本調査レポートでは、フェイスシールドの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、新型コロナウイルスの影響、製品別（フルフェイスシールド、ハーフフェイスシールド）分析、最終用途別（医療、建設、化学薬品、石油・ガス、製造、その他）分析、地域別分析、競争状況、企業概要などを整理しました。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・新型コロナウイルスの影響 ・フェイスシールドの世界市場規模：製品別（フルフェイスシールド、ハーフフェイスシールド） ・フェイスシールドの世界市場規模：最終用途別（医療、建設、化学薬品、石油・ガス、製造、その他） ・フェイスシールドの世界市場規模：地域別 ・競争状況 ・企業概要...Face Shield Market Growth & Trends The global face shields market size is expected to reach USD 5.4 billion by 2027 registering a CAGR of 15%, according to a new report by Grand View Research, Inc. Shortage of face shields in the healthcare industry and hospitality sector has increased the demand for new manufacturing technologies and product innovations in the market, which, in turn, will drive its growth. Many universities and educational facilities across the world are producing face shields using 3D printing techniques for frontline workers to meet the increased demand caused due to the Covid-19 pandemic. The major...
  5. 歯科生体材料の世界市場2020-2027：タイプ別（金属、セラミック、ポリマー）、用途別、最終用途別、地域別
    GV20JN096 / Grand View Research / 2020年5月 / 本調査レポートでは、歯科生体材料の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、タイプ別（金属、セラミック、ポリマー）分析、用途別分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・歯科生体材料の世界市場規模：タイプ別（金属、セラミック、ポリマー） ・歯科生体材料の世界市場規模：用途別 ・歯科生体材料の世界市場規模：最終用途別 ・歯科生体材料の世界市場規模：地域別 ・競争分析...Dental Biomaterials Market Growth & Trends The global dental biomaterials market size is expected to reach USD 12.3 billion by 2027, expanding at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Rising prevalence of tooth disorder is one of the major factors contributing to market growth. Dental biomaterials include biocompatible synthetic materials and natural tissues to restore tooth decay, damage, and fractures problems. As the geriatric population worldwide affected by tooth decay is huge despite significant advances in tooth restoration and caries prevention, the rising incidence of tooth disorder continues to pose a considerable...
  6. 生物学的安全キャビネットの世界市場2020-2027：製品タイプ別（クラスI、II、III）、最終用途別
    GV20JN094 / Grand View Research / 2020年5月 / 本調査レポートでは、生物学的安全キャビネットの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品タイプ別（クラスI、II、III）分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・生物学的安全キャビネットの世界市場規模：製品タイプ別（クラスI、II、III） ・生物学的安全キャビネットの世界市場規模：最終用途別 ・生物学的安全キャビネットの世界市場規模：地域別 ・競争分析...Biological Safety Cabinets Market Growth & Trends The global biological safety cabinets market size is expected to reach USD 282.1 million by 2027, registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Technological advancements due to a rise in laboratory procedures performed that play a crucial role in the safety of personnel, product, and environment, have propelled the market growth. The introduction of smart biosafety cabinets, such as PureLogic+ manufactured by Labconco Inc., with new features and adjustable accessories is playing a crucial role in the growth of the market. To improve the safety,...
  7. マルチパラメータ患者モニタリングシステムの世界市場2020-2027：デバイスタイプ別（固定型、携帯型）、視力レベル別、年齢層別、最終用途別、地域別
    GV20JN092 / Grand View Research / 2020年5月 / 本調査レポートでは、マルチパラメータ患者モニタリングシステムの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、デバイスタイプ別（固定型、携帯型）分析、視力レベル別分析、年齢層別分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・マルチパラメータ患者モニタリングシステムの世界市場規模：デバイスタイプ別（固定型、携帯型） ・マルチパラメータ患者モニタリングシステムの世界市場規模：視力レベル別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：年齢層別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：最終用途別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：地域別 ・競争分析...Multiparameter Patient Monitoring Systems Market Growth & Trends The global multiparameter patient monitoring systems market size is expected to reach USD 15.4 billion by 2027 registering a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Rising health concerns and resultant need to constantly monitor the health parameters of patients, before and after surgery is creating demand for multiparameter patient monitoring systems. The market growth is also supported by the increasing need for hospital transport, such as intrahospital or out-of-the-hospital transport. For special examination and therapy, hospitals require intrahospital transport, which calls for more continuous monitoring...
  8. バイオハザードバッグの世界市場2020-2027：材料別（HDPE、LDPE）、用途別、最終用途別、地域別
    GV20JN104 / Grand View Research / 2020年4月 / 本調査レポートでは、バイオハザードバッグの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、材料別（HDPE、LDPE）分析、用途別分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・バイオハザードバッグの世界市場規模：材料別（HDPE、LDPE） ・バイオハザードバッグの世界市場規模：用途別 ・バイオハザードバッグの世界市場規模：最終用途別 ・バイオハザードバッグの世界市場規模：地域別 ・競争分析...The global biohazard bags market size is anticipated to reach USD 472.3 million by 2027, expanding at a CAGR of 5.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing population base, increasing awareness regarding the critical role of waste disposal in controlling human infection, and the rising hospital/healthcare standards in developing countries have together contributed to the market growth. Waste disposal in biohazard bags is a critical step in maintaining the healthcare safety standards of medical institutions. Medical waste disposal in biohazard bags ensures that infectious waste isn’t exposed to the public and...
  9. 細菌・ウイルス検体コレクションの世界市場2020-2027：製品別（スワブ、採血キット、VTM）、用途別（診断、調査）、最終用途別、地域別
    GV20NV074 / Grand View Research / 2020年9月16日 / 本調査レポートでは、細菌・ウイルス検体コレクションの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、製品別市場規模（スワブ、採血キット、VTM）、用途別市場規模（診断、調査）、地域別市場規模、競争状況などの項目を掲載しています。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・競争分析 ・細菌・ウイルス検体コレクションの世界市場規模：製品別（スワブ、採血キット、VTM） ・細菌・ウイルス検体コレクションの世界市場規模：用途別（診断、調査） ・細菌・ウイルス検体コレクションの世界市場規模：地域別 ・競争状況...Bacterial & Viral Specimen Collection Growth & Trends The global bacterial and viral specimen collection market size is expected to reach USD 38.8 billion by 2027, expanding at a CAGR of 14.0%, according to a new report by Grand View Research, Inc. The advent of high-throughput methods, such as next-generation sequencing, multiplex PCR, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, allows rapid and affordable microbial identification and thus facilitates robust diseases diagnosis. This is increasing the demand for bacterial and viral specimen collecting products, thereby driving the market revenue. A rise in the prevalence of infectious diseases has encouraged diagnostic...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆